David Shaw’s Eikon Therapeutics EIKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$315K Buy
+39,240
New +$395K ﹤0.01% 4464

Other funds holding EIKN

David Shaw's EIKN Position: Q3 2026 in Review

David Shaw opened a new position in Eikon Therapeutics (EIKN) in Q3 2026: 39,240 shares worth $315K. The stake represents ﹤0.01% of the portfolio and ranks #4464 among its holdings.

96 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • David Shaw held 39,240 shares of Eikon Therapeutics worth $315K as of Q3 2026.
  • Eikon Therapeutics was a new David Shaw position in Q3 2026.
  • Eikon Therapeutics made up ﹤0.01% of David Shaw's portfolio in Q3 2026, its #4464 holding.
  • 96 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.